Drug intelligence / Profile preview

irisflorentin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical, Bath
01

Overview

Irisflorentin is a naturally occurring isoflavone compound derived from the roots of *Belamcanda chinensis* (L.) DC., a plant used in traditional Chinese medicine. It has the molecular formula C₂₀H₁₈O₈ and molecular weight of 386.35 g/mol. The compound exhibits multiple pharmacological activities including immunomodulatory, anti-inflammatory, and neuroprotective effects. Its mechanism involves modulation of dendritic cell properties through inhibition of NF-κB and MAPK signaling pathways (specifically IKK, JNK, and p38), reduction of proinflammatory cytokine production (TNF-α, IL-6, IL-12p70), and downregulation of costimulatory molecules (CD40, CD86) and MHC class II expression. In Parkinson's disease models, irisflorentin reduces α-synuclein accumulation by enhancing proteasome activity through upregulation of the proteasome regulatory subunit rpn-3. It also demonstrates protective effects against dopaminergic neuronal degeneration and reduces nitric oxide production by inhibiting inducible nitric oxide synthase (iNOS) expression in activated macrophages.

Other names
Irisflorentine5,3',4',5'-Tetramethoxy-6,7-methylenedioxyisoflavone9-methoxy-7-(3,4,5-trimethoxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one
02

Targets

JNK (Mitogen-activated protein kinase kinase kinase family)NOS2 (Nitric Oxide Synthase 2)MAPK14 (p38 mitogen-activated protein kinase alpha)NF-κBIL12 (Interleukin-12)CHUK (IKKα)TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)

Beyond the preview

Go deeper on irisflorentin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on irisflorentin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call